Common online cardiac rehabilitation curriculum: A seven-module online course covering cardiac rehabilitation principles, phase I and II rehabilitation, CPET, exercise prescription, the five prescriptions, multidisciplinary care, and acute-event management.
Matched supplementary online learning: Additional online case discussion and structured self-study assignments covering the same seven modules and matched in scheduled duration to the blended group's in-person sessions.
Hospital-based case and practice sessions: Seven supervised sessions in the cardiology ward, outpatient clinic, and CPET laboratory. Residents practice assessment, risk stratification, CPET interpretation, individualized exercise prescription, patient education, multidisciplinary planning, and simulated acute-event management with immediate instructor feedback.
This randomized controlled trial compares supervised hospital-based practice with matched online activities as part of a common cardiac rehabilitation curriculum for cardiology residents. Ninety-eight residents will be allocated 1:1 to a blended group or an online control group. Both groups will receive the same seven-module online curriculum and the same total scheduled learning time. The blended group will complete a matched block of in-person practice in the cardiology ward, outpatient clinic, and cardiopulmonary exercise testing laboratory, whereas the control group will complete matched-duration supplementary online activities. The primary outcome is the post-training 25-item cardiac rehabilitation knowledge score adjusted for the baseline score. Key secondary outcomes are Mini-CEX and procedure-specific DOPS scores assessed by assessors blinded to allocation.
| Facility | City | Region | Status |
|---|---|---|---|
| The Second Affiliated Hospital of Zhejiang University School of Medicine | Hangzhou | Zhejiang |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07755878 on ClinicalTrials.gov ↗ ← All trials in China